Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

China · Delayed Price · Currency is CNY

38.52

-1.23 (-3.09%)

Aug 24, 2026, 3:04 PM CST

-16.61% (1Y)

Market Cap	13.76B -16.2%
Revenue (ttm)	2.62B +23.0%
Net Income	756.37M +68.4%
EPS	2.12 +68.7%
Shares Out	357.32M
PE Ratio	18.13
Forward PE	n/a
Dividend	1.17 (2.92%)
Ex-Dividend Date	May 22, 2026

Volume	6,285,765
Open	39.68
Previous Close	39.75
Day's Range	38.45 - 39.80
52-Week Range	35.10 - 59.07
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicin... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1977

Employees 2,396

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300573

Full Company Profile

Financial Performance

In 2025, SHE:300573's revenue was 2.47 billion, an increase of 27.24% compared to the previous year's 1.94 billion. Earnings were 695.86 million, an increase of 105.84%.

Financial Statements